Skip to main content
An official website of the United States government

DCB at AACR 2023

Learn about NCI’s resources, programs, and funding opportunities available by joining us at the AACR Annual Meeting 2023 in Orlando.

DCB staff gave presentations and interacted with cancer biology researchers at the 2023 AACR Annual Meeting, which focused on advancing the frontiers of cancer science and medicine.

NCI-Selected Sessions Organized by DCB  

April 16, 2023, 4:00 PM - 5:00 PM
NCI Funding Opportunities in Cancer Immunoprevention and Chemoprevention (NIH07)
This session organized by DCB and the NCI Division of Cancer Prevention provided an overview of NCI funding opportunities and initiatives in cancer prevention and interception, including the Cancer Immunoprevention Network (CIP-Net), Human Tumor Atlas Network (HTAN) Pre-Cancer Atlas Centers, and the PREVENT Cancer Preclinical Drug Development Program

April 17, 2023, 4:00 PM - 5:00 PM
NIH Grants Session: Updates on Funding Policies and Review of NCI Applications (NIH06)
In this session, Dr. Dan Gallahan (DCB Director), Dr. Shannon Hughes (DCB Deputy Director), and Dr. Amy Rubenstein, (Chief of the Basic and Translational Cancer Review Branch within the NIH Center for Scientific Review) discussed current funding trends in basic cancer biology research, new grant policies, and changes in CSR review. 

A summary of the session can be found on Twitter
 

NCI Meet-the-Expert Sessions Presented by DCB Staff

Sunday, April 16, 1:30 -2:00 PM
NIH Research Enhancement Award (R15)
Drs. Ruibai Luo and Brunilde Gril (DCB Program Directors) gave an overview of NIH Research Enhancement Awards (R15s), eligibility, student involvement, and differences between AREA and REAP awards. 

Tuesday, April 18, 9:30 - 10:00 AM
Metastasis Research Network (MetNet)
Dr. Christine Nadeau (DCB Program Director) shared information about the MetNet program and current funding opportunity. 

Tuesday, April 18, 10:30 - 11:00 AM
Cancer Tissue Engineering Collaborative & Opportunities for Biomaterials Research
Dr. Steven Becker (DCB program Director) gave an overview of the Cancer Tissue Engineering Collaborative (TEC) and discussed opportunities to address cancer research questions using synthetic biology and materials science.  

Tuesday, April 18, 4:00 – 4:30 PM
Funding Opportunities in Cancer Biology
Dr. Claire McCarthy (DCB Communications Manager) shared current funding opportunities for fundamental cancer research that are supported by DCB. 
 

Videos of Poster Presentations Featuring DCB-Supported Researchers

DCB-supported researchers shared their cancer biology findings, which were presented at AACR 2023, in short videos:

  • Dr. Asmaa El-Kenawi showed that stress-mediated reactive oxygen species from mitochondria dysregulate the tumor microenvironment in prostate cancers of African American men. 
  • Dr. Matthew Kent shared how loss of HES3/her3 affects developmental and rhabdomyosarcoma related gene signatures in a zebrafish model.
  • Mercy Kehinde-Ige presented metabolic states of tumor-specific T cells that were determined using single-cell flux estimation analysis. 
  • Dr. Mahak Bhargava discussed her work on profiling the tumor microenvironments of triple- and quadruple-negative breast cancers.

DCB Social Media For AACR 2023

DCB social media posts about #AACR23 can be found on Twitter

Contact for DCB at AACR 2023  

For additional information about DCB activities at AACR 2023, please contact Dr. Claire McCarthy

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “DCB at AACR 2023 was originally published by the National Cancer Institute.”

Email